The Atrial Fibrillation Association in the UK was shocked by the decision by the National Institute for Health and Clinical Excellence (NICE) to deny atrial fibrillation patients access to dronedarone, a medication that has been approved in the U.S. and Europe. AFA is conducting a campaign to make the voices of atrial fibrillation patients heard. If you’re in the UK, and are as shocked as we are by NICE’s decision, please take action today.
Learn more about what you can do to influence NICE’s decision
After my first onset of AF... 8 months of persistent AF 24/7, I had an electrical cardioversion(CV) at Mass General Hosp.(MGH) in Boston then using sotalol and it lasted a week. Within a week MGH had me off sotalol and on Multaq for 5 days then CV on Oct. 5, 2009 without the three days in the hospital for sotalol and it has worked for me ( in normal sinus rthymn)...no side effects yet. My thyroid had been removed 7 years ago for cancer and I am on levoxyl...my dose did have to be slightly adjusted after Multaq but that had been happening with the other many drugs I took before the CV. Multaq works for me. The only drug left for me was amiodarone before Multaq was approved which luckily just happened to be FDA approved at the time of my first failed CV. I am concerned about the long term issues since the clinical trial test was for an aveage of about 20 months but very grateful this is working for me. My ejection fraction went from 45 with AF back to 60 after three months on Multaq. My life has been returned to me. I was pretty disabled with persistent AF.
- spam
- offensive
- disagree
- off topic
Like